Cumberland Pharmaceuticals (CPIX) Cash from Operations (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) posted Cash from Operations of 387025.0 for Q1 2026, up 12698.45% sequentially from 3024.0 in Q4 2025, and down 90.07% YoY from 3898517.0 in Q1 2025.
Cumberland Pharmaceuticals (CPIX) Cash from Operations (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals has reported Cash from Operations for 17 years, with the latest figure at 387025.0 in Q1 2026.
- Quarterly Cash from Operations fell 90.07% year-over-year to 387025.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1421030.0 (down 73.8% YoY) and the FY2025 annual result came in at 4932522.0, up 905.72% from the prior year.
- Cash from Operations climbed to 387025.0 in Q1 2026 per CPIX's latest filing, from 3024.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 5235361.0 in Q2 2023 and troughed at 2136647.0 in Q1 2024.
- A 5-year average of 1132622.24 and a median of 843801.0 in 2025 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2025: Cash from Operations slumped 842.34% in 2023, then surged 282.46% in 2025.
- Over 5 years, Cash from Operations stood at 3638031.0 in 2022, then sank by 71.41% to 1040121.0 in 2023, then soared by 83.12% to 1904618.0 in 2024, then tumbled by 99.84% to 3024.0 in 2025, then soared by 12698.45% to 387025.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 387025.0, 3024.0, and 187180.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.68 Mn | 110.82 Mn | - | -3.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.88 Mn |
| Jun 30, 2026 | -3.88 Mn |
| Mar 31, 2026 | 387,025.00 |
| Mar 31, 2026 | 387,025.00 |
| Dec 31, 2025 | 3,024.00 |
| Dec 31, 2025 | 3,024.00 |
| Sep 30, 2025 | 187,180.00 |
| Sep 30, 2025 | 187,180.00 |
| Jun 30, 2025 | 843,801.00 |
| Jun 30, 2025 | 843,801.00 |
| Mar 31, 2025 | 3.90 Mn |
| Mar 31, 2025 | 3.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Dec 31, 2024 | 1.90 Mn |
| Sep 30, 2024 | 475,503.00 |
| Sep 30, 2024 | 475,503.00 |
| Jun 30, 2024 | -855,660.00 |
| Jun 30, 2024 | -855,660.00 |
| Mar 31, 2024 | -2.14 Mn |
| Mar 31, 2024 | -2.14 Mn |